Cargando…
Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia.
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935868/ https://www.ncbi.nlm.nih.gov/pubmed/36816449 http://dx.doi.org/10.1155/2023/3226278 |
_version_ | 1784890107348647936 |
---|---|
author | Hasan, Haytham Surjancev, Ivana Arnason, Jon A. Garg, Shivani Rose, William Nicholas |
author_facet | Hasan, Haytham Surjancev, Ivana Arnason, Jon A. Garg, Shivani Rose, William Nicholas |
author_sort | Hasan, Haytham |
collection | PubMed |
description | We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia. |
format | Online Article Text |
id | pubmed-9935868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-99358682023-02-18 Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia Hasan, Haytham Surjancev, Ivana Arnason, Jon A. Garg, Shivani Rose, William Nicholas Case Rep Rheumatol Case Report We report a patient with catastrophic antiphospholipid syndrome who had significant improvement after corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus. Argatroban was used instead of heparin due to a history of heparin-induced thrombocytopenia. Hindawi 2023-02-09 /pmc/articles/PMC9935868/ /pubmed/36816449 http://dx.doi.org/10.1155/2023/3226278 Text en Copyright © 2023 Haytham Hasan et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Hasan, Haytham Surjancev, Ivana Arnason, Jon A. Garg, Shivani Rose, William Nicholas Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia |
title | Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia |
title_full | Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia |
title_fullStr | Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia |
title_full_unstemmed | Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia |
title_short | Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia |
title_sort | corticosteroids, plasmapheresis, argatroban, rituximab, and sirolimus provided clinical benefit for catastrophic antiphospholipid syndrome in a patient with a history of heparin-induced thrombocytopenia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935868/ https://www.ncbi.nlm.nih.gov/pubmed/36816449 http://dx.doi.org/10.1155/2023/3226278 |
work_keys_str_mv | AT hasanhaytham corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia AT surjancevivana corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia AT arnasonjona corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia AT gargshivani corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia AT rosewilliamnicholas corticosteroidsplasmapheresisargatrobanrituximabandsirolimusprovidedclinicalbenefitforcatastrophicantiphospholipidsyndromeinapatientwithahistoryofheparininducedthrombocytopenia |